HTL vs. QIPT, CRDL, CPH, MDNA, OGI, EDT, DR, HLS, ONC, and SVA
Should you be buying Hamilton Thorne stock or one of its competitors? The main competitors of Hamilton Thorne include Quipt Home Medical (QIPT), Cardiol Therapeutics (CRDL), Cipher Pharmaceuticals (CPH), Medicenna Therapeutics (MDNA), Organigram (OGI), Spectral Medical (EDT), Medical Facilities (DR), HLS Therapeutics (HLS), Oncolytics Biotech (ONC), and Sernova (SVA). These companies are all part of the "medical" sector.
Hamilton Thorne (TSE:HTL) and Quipt Home Medical (TSE:QIPT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.
In the previous week, Hamilton Thorne had 12 more articles in the media than Quipt Home Medical. MarketBeat recorded 16 mentions for Hamilton Thorne and 4 mentions for Quipt Home Medical. Quipt Home Medical's average media sentiment score of -0.14 beat Hamilton Thorne's score of -0.37 indicating that Quipt Home Medical is being referred to more favorably in the news media.
Quipt Home Medical has a consensus price target of C$10.87, indicating a potential upside of 155.16%. Given Quipt Home Medical's stronger consensus rating and higher probable upside, analysts clearly believe Quipt Home Medical is more favorable than Hamilton Thorne.
Hamilton Thorne has higher earnings, but lower revenue than Quipt Home Medical. Hamilton Thorne is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.
19.5% of Hamilton Thorne shares are held by institutional investors. Comparatively, 45.1% of Quipt Home Medical shares are held by institutional investors. 27.8% of Hamilton Thorne shares are held by insiders. Comparatively, 3.8% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Hamilton Thorne has a net margin of -0.90% compared to Quipt Home Medical's net margin of -1.57%. Hamilton Thorne's return on equity of -1.00% beat Quipt Home Medical's return on equity.
Hamilton Thorne has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500.
Quipt Home Medical received 12 more outperform votes than Hamilton Thorne when rated by MarketBeat users. However, 100.00% of users gave Hamilton Thorne an outperform vote while only 81.25% of users gave Quipt Home Medical an outperform vote.
Summary
Quipt Home Medical beats Hamilton Thorne on 10 of the 18 factors compared between the two stocks.
Get Hamilton Thorne News Delivered to You Automatically
Sign up to receive the latest news and ratings for HTL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hamilton Thorne Competitors List
Related Companies and Tools
